|
Asociación de linfomas malignos con Herpes Virus I y II. Alarcón Rozas, Ashley Efrain. |
BIBLIOGRAFÍA
1.- Niitsu N, Chizuca A, Sasaki N, Umeda
M. Human herpes virus-8 associated with two cases of primary-effusion lymphoma. Ann
Hematol (2000) 79: 336-339
2.- Fogarty International Center, NIH, Institute Pasteur. Viruses and Human Cancers:
Challenges for preventive strategies. Environt Health Perspect. 1995 Nov; 1003 Suppl 8:
269-273
3.- Nador R, Cesarman F, Chadburn A, Dawson D, Ansari M, Sald J, Knowles DM. Primary
effusion lymphoma: a distinct clinico pathologic entity associated with the Kaposi´s
sarcoma-associated herpes virus. Blood 1996; 88: 645-656.
4.- Chang Y, Cesarman F, Pessin MS, Lee F, Culpepper J, Knowles DM et al. Identification
of herpesvirus-like DNA secuences in AIDS-associated Kaposi{s sarcoma. Science
1994;266:1865
5.- Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M, et al.
Isolation of a new virus, HBLV, in patient with lymphoproliferative disorders. Science;
1986; 234:596
6.- Wyatt LS, Frenkel N. Human herpes virus 7 is a constitutive inhabitant of adult human
saliva. J Virol 1992; 66:3206
7.- Yamanishi K, Okuno T, Shiraki, Takahashi M, Kondo T, Asano Y, et al. Identification of
human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1988;1:1065
8.- Mori S. Human herpes virus and malignancies. Rinisho Byori 2001 Aug;49(8):775-778
9.- Ansari MQ, Dawson DB, Nador R, et al. Primary body-cavity based AIDS-relates
lymphomas. AM J Clin Pathol 1996:105;21-229
10.- Polito P,Carzonien V, Cilice AM, et al. Structural abnormality of 1q in an
AIDS-related body-cavity based lymphoma. Int J Cancer 1996;67: 588-590
11.- Strauchen JA, Heuser AD, Burnstein D, et al. Body-cavity based malignant lymphoma
containing Kaposi sarcoma-associated herpes virus in an HIV-negative men with primary
Kaposi sarcoma Ann Int Med 1996; 125:222-225
12.- Cokic-Damjanovic J, Jovanovic J. Herpes simplex virus and ovarian malignancies. Med
Pregl 1995;48(9,10):311-314
13.- Di Paolo JA, Woodworth CD, Cantlec F, Zimovic DB, Bryant J, Kernoes A. Relationship
of stable integration of herpes virus simplex-2 Bg/IIN subfragment Xho to malignant
transform of HPV-inmortalized cervical keratinocites. Int J Cancer 1998 Jun
10;76(6):865-867
14.- Ambroster C; Drlicek . Herpes virus type II infection as an exophitic endobronchial
tumor. Wien Klin Wochenschr 1995; 107(11):344-346
15.- Kao Y, Sundin D, Gebhardt B. Persistent infection of a lymphoma cell line by herpes
simplex virus Am J Hem 1999;62:93-98
16.- Rinaldo CR, Richter BS, Black PH, Callery R, Chess L, Hirsh MS. Replication of herpes
simplex virus and citomegalovirus in human leukocites. J Immunol 1978;120:130-136.
17.- Youssufian H, Hammer SM, Hirsh MS, Mulder C Methilation of the virus genome in an in
vitro model of herpes simplex virus latency. Proct Natl Acad Scie 1982;79:2207-2210.
18.- Gao SJ,Kinsley I, Li M, et al. KSHV antibodies among americans, Italians and Ugandans
with and without Kaposi{s sarcoma. Nat Med 1996;2:925-928
19.- Kedes D, Operalski E, Busch M, et al . The seroepidemiology of human herpes virus 8:
Distribution of infection in KS risk groups and evidence for sexual transmission . Nat Med
1996;2:918-924
20.- Enbern M, Tolfrestain T, Ghebrekidan h, et al. Seroprevalence of Human herpes virus 8
in different Eritrean population groups. J Clin Virol 1999;14(3):167-172
